Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[About two cases of massive hypercholesterolemia].

C Perier1, N Raby, S Atieh

  • 1Laboratoire de biochimie, hôpital Nord, CHU, hôpitaux de Saint-Etienne, Saint-Etienne, France. christian.perier@chu-st-etienne.fr

Annales De Biologie Clinique
|March 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates.

Science advances·2020
Same author

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.

Cell death & disease·2014
Same author

Separation of amino acids using ion-paired reversed-phase high-performance liquid chromatography with special reference to collagen hydrolysate.

Amino acids·2013
Same author

An improved scheme of leucine derivative fragmentation in mass spectrometry.

Amino acids·2013
Same author

Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency.

Cell death and differentiation·2012
Same author

Neurotoxin-based models of Parkinson's disease.

Neuroscience·2011
Same journal

[The role of the heart-on-a-chip to drug evaluation].

Annales de biologie clinique·2026
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
See all related articles

Massive hypercholesterolemia in two patients stemmed from acquired diseases, not primary causes. Their unique lipoprotein patterns revealed distinct disease mechanisms.

Area of Science:

  • Biochemistry
  • Pathophysiology
  • Clinical Medicine

Background:

  • Hypercholesterolemia, characterized by elevated cholesterol levels, is a significant risk factor for cardiovascular disease.
  • Primary hypercholesterolemia results from genetic factors, while acquired forms arise from secondary conditions.
  • Understanding the distinct pathophysiological mechanisms of different hypercholesterolemia types is crucial for effective management.

Observation:

  • Two patients presented with severe hypercholesterolemia.
  • The underlying causes were identified as intrahepatic cholangitis with cholestasis in one case and nephrotic syndrome in the other.
  • Lipoprotein patterns were analyzed to understand the lipid metabolism alterations.

Findings:

  • The lipoprotein patterns in these acquired hypercholesterolemia cases differed significantly from those observed in primary hypercholesterolemia.

Related Experiment Videos

  • Distinct pathophysiological processes were identified, highlighting the unique lipid alterations associated with intrahepatic cholangitis and nephrotic syndrome.
  • These findings suggest that acquired hypercholesterolemia may involve different molecular pathways compared to genetic forms.

    • Implications:

    • The study underscores the importance of identifying the underlying cause of hypercholesterolemia to guide treatment strategies.
    • Recognizing distinct pathophysiological mechanisms in acquired hypercholesterolemia can lead to more targeted therapeutic interventions.
    • Further research into acquired hypercholesterolemia is warranted to elucidate specific molecular targets and improve patient outcomes.